WINDLASPharmaceuticals
Windlas Biotech Ltd — Balance Sheet
₹736.75
-1.94%
Windlas Biotech Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Liabilities Net Minority Interest | 254.68 Cr | 176.27 Cr | 126.70 Cr | 96.23 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 5.24 Cr | 4.52 Cr | 5.46 Cr | 2.25 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 2.88 Cr | 2.32 Cr | 2.02 Cr | 1.57 Cr | — |
| Long Term Debt And Capital Lease Obligation | 2.25 Cr | 2.02 Cr | 3.13 Cr | 0.44 Cr | — |
| Long Term Capital Lease Obligation | 2.25 Cr | 2.02 Cr | 3.02 Cr | 0.00 | — |
| Long Term Debt | 0.00 | 0.00 | 0.11 Cr | 0.44 Cr | — |
| Long Term Provisions | 2.88 Cr | 2.32 Cr | 2.02 Cr | — | — |
| Current Liabilities | 249.44 Cr | 171.75 Cr | 121.24 Cr | 93.99 Cr | — |
| Other Current Liabilities | 12.77 Cr | 4.67 Cr | 4.15 Cr | 1.50 Cr | — |
| Current Debt And Capital Lease Obligation | 30.35 Cr | 1.62 Cr | 1.87 Cr | 6.19 Cr | — |
| Current Capital Lease Obligation | 3.23 Cr | 1.51 Cr | 1.53 Cr | 0.52 Cr | — |
| Current Debt | 27.12 Cr | 0.11 Cr | 0.34 Cr | 5.68 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 1.56 Cr | 0.72 Cr | 0.45 Cr | 0.33 Cr | — |
| Current Provisions | 1.56 Cr | 0.72 Cr | 0.45 Cr | — | — |
| Payables | 167.24 Cr | 146.65 Cr | 99.11 Cr | 70.75 Cr | — |
| Other Payable | 18.67 Cr | 15.12 Cr | 11.37 Cr | 7.52 Cr | — |
| Dividends Payable | 0.02 Cr | 0.02 Cr | 0.00 | — | — |
| Accounts Payable | 167.24 Cr | 131.51 Cr | 87.74 Cr | 63.23 Cr | — |
| Total Assets | 760.45 Cr | 626.21 Cr | 528.98 Cr | 491.01 Cr | — |
| Total Non Current Assets | 235.32 Cr | 194.92 Cr | 175.44 Cr | 109.36 Cr | — |
| Other Non Current Assets | 2.07 Cr | -10000.00 | 41.59 Cr | 20000.00 | — |
| Non Current Prepaid Assets | 3.73 Cr | 2.78 Cr | 4.64 Cr | 5.41 Cr | — |
| Non Current Deferred Taxes Assets | 0.28 Cr | 0.57 Cr | 2.02 Cr | 2.04 Cr | — |
| Investmentin Financial Assets | 4.26 Cr | 1.64 Cr | 5.24 Cr | 2.31 Cr | — |
| Available For Sale Securities | 4.26 Cr | 1.64 Cr | 5.24 Cr | 2.31 Cr | — |
| Goodwill And Other Intangible Assets | 6.78 Cr | 4.47 Cr | 1.48 Cr | 0.88 Cr | — |
| Other Intangible Assets | 6.78 Cr | 4.47 Cr | 1.48 Cr | 0.88 Cr | — |
| Net PPE | 221.93 Cr | 185.12 Cr | 161.47 Cr | 98.47 Cr | — |
| Accumulated Depreciation | -118.61 Cr | -92.06 Cr | -81.51 Cr | -69.50 Cr | — |
| Gross PPE | 221.93 Cr | 277.18 Cr | 242.99 Cr | 167.97 Cr | — |
| Construction In Progress | 3.20 Cr | 10.54 Cr | 52.57 Cr | 7.73 Cr | — |
| Other Properties | 218.73 Cr | 5.85 Cr | 3.74 Cr | 3.64 Cr | — |
| Machinery Furniture Equipment | 193.75 Cr | 160.59 Cr | 98.84 Cr | 85.41 Cr | — |
| Buildings And Improvements | 87.67 Cr | 67.33 Cr | 54.98 Cr | 48.12 Cr | — |
| Land And Improvements | 49.32 Cr | 32.86 Cr | 32.86 Cr | 23.07 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 525.13 Cr | 431.29 Cr | 353.54 Cr | 381.65 Cr | — |
| Other Current Assets | 33.31 Cr | 26.22 Cr | 28.50 Cr | -10000.00 | — |
| Restricted Cash | 1.59 Cr | 0.11 Cr | 0.06 Cr | 0.16 Cr | — |
| Prepaid Assets | 36.79 Cr | 27.66 Cr | 29.48 Cr | 31.23 Cr | — |
| Inventory | 81.38 Cr | 62.19 Cr | 74.74 Cr | 58.71 Cr | — |
| Finished Goods | 45.17 Cr | 21.75 Cr | 17.04 Cr | 13.09 Cr | — |
| Work In Process | 1.76 Cr | 3.65 Cr | 17.95 Cr | 6.63 Cr | — |
| Raw Materials | 34.46 Cr | 36.79 Cr | 39.75 Cr | 38.98 Cr | — |
| Other Receivables | 0.58 Cr | 0.67 Cr | 0.44 Cr | 2.21 Cr | — |
| Taxes Receivable | 3.28 Cr | 0.69 Cr | — | 4.10 Cr | — |
| Accounts Receivable | 166.86 Cr | 136.28 Cr | 116.86 Cr | 110.77 Cr | — |
| Allowance For Doubtful Accounts Receivable | -2.41 Cr | -3.60 Cr | -3.39 Cr | -1.12 Cr | — |
| Gross Accounts Receivable | 169.27 Cr | 139.88 Cr | 120.25 Cr | 111.89 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 240.30 Cr | 204.38 Cr | 131.97 Cr | 178.57 Cr | — |
| Other Short Term Investments | 239.87 Cr | 199.09 Cr | 128.28 Cr | 178.00 Cr | — |
| Cash And Cash Equivalents | 0.42 Cr | 5.29 Cr | 3.69 Cr | 0.57 Cr | — |
| Cash Equivalents | 0.00 | 0.02 Cr | 0.00 | 0.18 Cr | — |
| Cash Financial | 0.42 Cr | 5.27 Cr | 3.69 Cr | 0.39 Cr | — |
| Ordinary Shares Number | 2.10 Cr | 2.08 Cr | 2.09 Cr | 2.18 Cr | — |
| Share Issued | 2.10 Cr | 2.08 Cr | 2.18 Cr | 2.18 Cr | — |
| Net Debt | 26.69 Cr | — | — | 5.55 Cr | 15.39 Cr |
| Total Debt | 32.60 Cr | 3.64 Cr | 4.99 Cr | 6.64 Cr | — |
| Tangible Book Value | 498.99 Cr | 445.47 Cr | 400.79 Cr | 393.89 Cr | — |
| Invested Capital | 532.89 Cr | 450.05 Cr | 402.71 Cr | 400.90 Cr | — |
| Working Capital | 275.69 Cr | 259.54 Cr | 232.29 Cr | 287.67 Cr | — |
| Net Tangible Assets | 498.99 Cr | 445.47 Cr | 400.79 Cr | 393.89 Cr | — |
| Capital Lease Obligations | 5.48 Cr | 3.53 Cr | 4.55 Cr | 0.52 Cr | — |
| Common Stock Equity | 505.77 Cr | 449.94 Cr | 402.27 Cr | 394.78 Cr | — |
| Total Capitalization | 505.77 Cr | 449.94 Cr | 402.38 Cr | 395.22 Cr | — |
| Total Equity Gross Minority Interest | 505.77 Cr | 449.94 Cr | 402.27 Cr | 394.78 Cr | — |
| Stockholders Equity | 505.77 Cr | 449.94 Cr | 402.27 Cr | 394.78 Cr | — |
| Other Equity Interest | 495.29 Cr | 4.89 Cr | 2.82 Cr | 1.81 Cr | — |
| Retained Earnings | 274.93 Cr | 225.97 Cr | 176.35 Cr | 141.50 Cr | — |
| Additional Paid In Capital | 199.44 Cr | 195.09 Cr | 199.05 Cr | 226.95 Cr | — |
| Capital Stock | 10.48 Cr | 10.40 Cr | 10.46 Cr | 10.90 Cr | — |
| Common Stock | 10.48 Cr | 10.40 Cr | 10.46 Cr | 10.90 Cr | — |
| Current Deferred Taxes Liabilities | — | 0.00 | 0.59 Cr | 0.00 | 0.00 |
| Total Tax Payable | — | 0.00 | 0.59 Cr | — | — |
| Treasury Shares Number | — | — | 0.09 Cr | — | — |
| Other Non Current Liabilities | — | — | — | 40000.00 | — |
| Non Current Deferred Taxes Liabilities | — | — | — | 0.00 | 0.68 Cr |
| Goodwill | — | — | — | 0.00 | 0.00 |
| Other Inventories | — | — | — | 10000.00 | — |
| Long Term Equity Investment | — | — | — | — | 0.00 |
| Investmentsin Associatesat Cost | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Windlas Biotech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.